Low-dose oral contraceptive usage and coagulation
- 1 September 1981
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 141 (1) , 71-75
- https://doi.org/10.1016/0002-9378(81)90677-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations.BMJ, 1980
- ORAL CONTRACEPTIVES AND THROMBOEMBOLIC DISEASE: EFFECTS OF LOWERING ŒSTROGEN CONTENTThe Lancet, 1980
- THE ROLE OF HYPERCOAGULABILITY IN THROMBOSISBritish Journal of Haematology, 1978
- Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and ProgestinsNew England Journal of Medicine, 1978
- HÆMOSTATIC, LIPID, AND BLOOD-PRESSURE PROFILES OF WOMEN ON ORAL CONTRACEPTIVES CONTAINING 50 µg OR 30 µg ŒSTROGENThe Lancet, 1977
- Myocardial infarction in young women with special reference to oral contraceptive practice.BMJ, 1975
- Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of DrugsBMJ, 1970
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957